Central Organization Institute of Legal Education (ILE) • Master Scholarly Repository & Academic Law Journals
Institute of Legal Education

Institute of Legal Education

Premier Scholarly Publishing House, Central Legal Research Repository & Academic Network
Home › Repository › Article Details
ILE-AIT-15157 Indian Journal of Legal Review (IJLR)
✓ Double-Blind Peer Reviewed 🔓 Open Access

ROLE OF JUDICIARY IN COMPULSORY LICENSING REGIME

Author(s): INDIAN JOURNAL OF LEGAL REVIEW
Volume: 4 Issue: 2 Year: 2025 ISSN: 2583-2344 APIS: 3920-0001 Publisher: Institute of Legal Education (ILE)
Recommended Bluebook Citation
INDIAN JOURNAL OF LEGAL REVIEW, ROLE OF JUDICIARY IN COMPULSORY LICENSING REGIME, 4 Indian Journal of Legal Review 2 (2025).

Abstract

ROLE OF JUDICIARY IN COMPULSORY LICENSING REGIME

AUTHOR – SWATI GUPTA, LLM SCHOLAR AT AMITY UNIVERSITY NOIDA

BEST CITATION - SWATI GUPTA, ROLE OF JUDICIARY IN COMPULSORY LICENSING REGIME, INDIAN JOURNAL OF LEGAL REVIEW (IJLR), 5 (4) OF 2025, PG. 774-787, APIS – 3920 – 0001 & ISSN - 2583-2344.

Abstract

  This chapter delves into the critical role of the Indian judiciary in shaping the compulsory licensing regime for pharmaceutical patents under the Indian Patents Act, 1970 (as amended), within the context of international obligations and public health imperatives. Employing a doctrinal and case law analysis, the chapter examines key judicial pronouncements, including the landmark cases of Natco Pharma Ltd. v. Bayer Corporation, BDR Pharmaceuticals International Pvt Ltd v. Bristol-Myers Squibb Co, Lee Pharma v. AstraZeneca, and Novartis Ag v. Union of India and Others. The analysis highlights the judiciary's general inclination towards a public health-oriented interpretation of compulsory licensing, demonstrated by the granting of the first compulsory license in Natco v. Bayer based on unmet public needs and unaffordable pricing. Conversely, the rejections in BDR Pharma and Lee Pharma underscore the significance of fulfilling statutory prerequisites and demonstrating genuine efforts to secure voluntary licenses. Furthermore, the chapter analyzes the pivotal role of the judiciary in upholding Section 3(d) of the Patents Act, as seen in the Novartis case, in preventing patent evergreening and safeguarding the accessibility of generic medicines. The chapter critically reflects on the complexities and potential obsolescence of the current compulsory licensing process and argues for its streamlining. It underscores the significance of India's judicial approach as a potential model for developing nations seeking to utilize TRIPS flexibilities to address public health crises and ensure access to affordable pharmaceuticals.

← Back to Repository Search